These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 12885833)
1. Down syndrome and acute myeloid leukemia: the paradox of increased risk for leukemia and heightened sensitivity to chemotherapy. Ravindranath Y J Clin Oncol; 2003 Sep; 21(18):3385-7. PubMed ID: 12885833 [No Abstract] [Full Text] [Related]
2. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891. Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO; J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836 [TBL] [Abstract][Full Text] [Related]
3. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M; Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916 [TBL] [Abstract][Full Text] [Related]
7. Optimizing therapy for myeloid disorders of Down syndrome. Webb DK Br J Haematol; 2005 Oct; 131(1):3-7. PubMed ID: 16173956 [TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review. Gamis AS Pediatr Blood Cancer; 2005 Jan; 44(1):13-20. PubMed ID: 15534881 [TBL] [Abstract][Full Text] [Related]
9. Trisomy 11 limited to trisomy 21 cells in a mosaic Down syndrome child with acute myeloid leukemia. Punnett HH; Dampier C Med Pediatr Oncol; 2003 Jul; 41(1):69-70. PubMed ID: 12764749 [No Abstract] [Full Text] [Related]
10. Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature. Abildgaard L; Ellebaek E; Gustafsson G; Abrahamsson J; Hovi L; Jonmundsson G; Zeller B; Hasle H Ann Hematol; 2006 May; 85(5):275-80. PubMed ID: 16518605 [TBL] [Abstract][Full Text] [Related]
11. Down syndrome, drug metabolism and chromosome 21. Taub JW; Ge Y Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307 [TBL] [Abstract][Full Text] [Related]
12. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group. Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I; J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827 [TBL] [Abstract][Full Text] [Related]
13. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia. Kobayashi R; Tawa A; Hanada R; Horibe K; Tsuchida M; Tsukimoto I; Pediatr Blood Cancer; 2007 Apr; 48(4):393-8. PubMed ID: 16550530 [TBL] [Abstract][Full Text] [Related]
14. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostics and therapy of acute myeloid leukemia]. Fritsch S; Metzeler K; Hiddemann W; Buske C Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056 [No Abstract] [Full Text] [Related]
17. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy. Gupta V; Chun K; Yi QL; Minden M; Schuh A; Wells R; Brandwein J Cancer; 2005 May; 103(10):2082-90. PubMed ID: 15830348 [TBL] [Abstract][Full Text] [Related]
18. [Relapsed acute myeloid leukemia with Down syndrome showing long disease-free survival after bone marrow transplantation]. Daifu T; Kato I; Matubara H; Abe D; Uryu K; Tokumasu M; Umeda K; Watanabe K; Izawa K; Asai K; Nakahata T; Adachi S Rinsho Ketsueki; 2009 Feb; 50(2):73-7. PubMed ID: 19265297 [TBL] [Abstract][Full Text] [Related]
19. Down syndrome and acute lymphoblastic leukaemia. Whitlock JA Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672 [TBL] [Abstract][Full Text] [Related]
20. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H; Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]